Looks like one of those general interest stories you can find in any newspaper, put out by PR to prop up the company. No technical details, secret sauce, seems

Looks like one of those general interest stories you can find in any newspaper, put out by PR to prop up the company. No technical details, secret sauce, seems similar to just filling up with gelatin, except in expensive pills. Not really 'hard biotech', not worth the attention, in short. P.S. Yesterday, for instance, I voted up that 'paid comments' site link, not because I think it's a good idea, but because it might generate some interesting comments. I don't think it's the case with this, or economics/etc discussions which quickly degenerate into pointless squabbling. Been around that block with Usenet, and the experience hasn't improved - nowadays there's not even killfiles, and the reading is slower. Not looking good.